NCT01540487 - Pharmacokinetics of Fixed Dose Combination (FDC) Tablets of Linagliptin /Metformin | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2012

Study Completion Date

June 30, 2012

Conditions

Healthy

Interventions

DRUG

linagliptin/metformin(high dose)

patient would take fixed dose combination tablets of linagliptin /metformin (high dose) and single linagliptin and metformin (High dose) tablets single dose in random order, and each dosage will be separated in 42 days interval.

DRUG

Linagliptin/metformin(low dose)

patient would take fixed dose combination tablets of linagliptin /metformin (low dose) and single linagliptin and metformin (Low dose) tablets single dose in random order, and each dosage will be separated in 42 days interval.

Trial Locations (1)

Unknown

1288.5.86001 Boehringer Ingelheim Investigational Site, Beijing